Related Experiment Video
Updated: Sep 8, 2025

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
Published on: November 22, 2019
Directed Acyclic Graphs in Oncology Research: Applications and Illustrated Example
Analisa Jia1,2, Lisa Kuramoto3, Brian Lam1
1Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Directed Acyclic Graphs (DAGs) help visualize cancer's complex causes. This study shows how to use DAGs in skin cancer research to improve causal inference and control for confounding factors.
Area of Science:
- Oncology
- Epidemiology
- Causal Inference
Background:
- Cancer development involves multifactorial risk factors, necessitating clear understanding of causal relationships.
- Observational studies in oncology require robust methods to identify and address confounding, mediation, and colliders.
Purpose of the Study:
- To present the development and application of Directed Acyclic Graphs (DAGs) in a real-world skin cancer observational study.
- To provide a practical guide for constructing and utilizing DAGs to control for confounding in cancer research.
Main Methods:
- Development and application of a Directed Acyclic Graph (DAG) framework.
- Utilizing DAGs for variable selection to manage confounding in observational data.
- Illustrative case study involving skin cancer research.
Main Results:
- Demonstrated the practical utility of DAGs in a real-world skin cancer study.
- Outlined actionable steps for DAG construction and confounder identification.
- Enhanced the ability to estimate causal effects in observational oncology research.
Conclusions:
- DAGs are essential tools for elucidating complex causal relationships in cancer research.
- This approach improves the transparency and validity of causal claims in oncology.
- Provides a valuable guide for researchers across various cancer research domains.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

